Functional impairment of human resident cardiac stem cells by the cardiotoxic antineoplastic agent trastuzumab.
about
Cardiac toxicity of trastuzumab in elderly patients with breast cancerCancer drug related cardiotoxicity during breast cancer treatment.A corrole nanobiologic elicits tissue-activated MRI contrast enhancement and tumor-targeted toxicityCardiovascular toxicity associated with adjuvant trastuzumab therapy: prevalence, patient characteristics, and risk factors.A bioengineered hydrogel system enables targeted and sustained intramyocardial delivery of neuregulin, activating the cardiomyocyte cell cycle and enhancing ventricular function in a murine model of ischemic cardiomyopathy.An update on cardio-oncology.Trastuzumab alters the expression of genes essential for cardiac function and induces ultrastructural changes of cardiomyocytes in mice.Epigenomic Reprogramming of Adult Cardiomyocyte-Derived Cardiac Progenitor CellsBone Marrow Is a Reservoir for Cardiac Resident Stem Cells.Benefits of antihypertensive medications for anthracycline- and trastuzumab-induced cardiotoxicity in patients with breast cancer: Insights from recent clinical trials.The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC-derived cardiomyocytes.Localisation Microscopy of Breast Epithelial ErbB-2 Receptors and Gap Junctions: Trafficking after γ-Irradiation, Neuregulin-1β, and Trastuzumab Application.Serum and supplement optimization for EU GMP-compliance in cardiospheres cell culture.EMT/MET at the Crossroad of Stemness, Regeneration and Oncogenesis: The Ying-Yang Equilibrium Recapitulated in Cell Spheroids.Doxorubicin upregulates CXCR4 via miR-200c/ZEB1-dependent mechanism in human cardiac mesenchymal progenitor cells.Cardiac Nonmyocyte Cell Functions and Crosstalks in Response to Cardiotoxic Drugs.
P2860
Q26741182-C09BE1E2-23D1-45D2-8883-28A4BA008049Q30251498-F1FAB2A0-00F8-4672-8D46-EC28DC60C4FAQ30991229-451C19D3-992A-47C8-9992-02F4357FC2B5Q33949465-22D3A5B8-3569-4A4E-9529-FC9E4747B125Q34149206-A057244F-EBAA-400E-A801-92500B376A36Q34650059-CF214E90-F492-4970-A15F-3C8A90D2FA57Q35047415-D4AC9C26-914E-4B79-8A76-13A53508D9C2Q36367191-F0FCA570-921A-449C-8BBF-1588B862CED1Q37039803-81CED5D1-9512-48C8-AC05-FF690E1AF968Q37311943-899A04D7-E42D-4ABA-B83F-01D71F56A754Q37592520-DDFFA4A8-DE5C-4A8C-924A-D43C715ED03FQ37690877-9B5F5A8D-2695-4663-8AFD-5E5748BDB632Q37724023-F14946AE-F501-45F7-8427-6FF9F2816245Q38652053-3175B48B-1A23-45F4-9540-251D18FD4389Q41167795-0194F56F-4D46-406C-8434-92E68FC5F6EAQ47149101-24273100-47F4-402E-B83C-6F4BDA033D7C
P2860
Functional impairment of human resident cardiac stem cells by the cardiotoxic antineoplastic agent trastuzumab.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Functional impairment of human ...... ineoplastic agent trastuzumab.
@en
type
label
Functional impairment of human ...... ineoplastic agent trastuzumab.
@en
prefLabel
Functional impairment of human ...... ineoplastic agent trastuzumab.
@en
P2093
P2860
P356
P1476
Functional impairment of human ...... ineoplastic agent trastuzumab.
@en
P2093
Alice S Ho
Andreas S Barth
Antonio C Wolff
Brian O'Rourke
Darryl R Davis
Eddy Kizana
Eduardo Marbán
Gary Gerstenblith
Ioannis Terrovitis
Isotta Chimenti
P2860
P304
P356
10.5966/SCTM.2011-0016
P577
2012-04-10T00:00:00Z